Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADC Agree

Trading 03-26 14:53:56 EDT

74.57

+0.35

+0.47%

High74.96	Low74.06	Vol392.05K
Open74.14	D1 Closing74.22	Amplitude1.21%
Mkt Cap8.95B	Tradable Cap8.08B	Total Shares120.03M
T/O29.29M	T/O Rate0.36%	Tradable Shares108.37M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"Agree","latestPrice":74.57,"timestamp":1774551234419,"preClose":74.22,"halted":0,"volume":392045,"delay":0,"changeRate":0.004715710051199061,"floatShares":108366822,"shares":120028300,"eps":1.77,"marketStatus":"Trading","change":0.35,"latestTime":"03-26 14:53:56 EDT","open":74.14,"high":74.96,"low":74.06,"amount":29288727.320425,"amplitude":0.012126,"askPrice":74.6,"askSize":155,"bidPrice":74.54,"bidSize":12,"shortable":3,"etf":0,"ttmEps":1.77,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1774555200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":74.22,"dividendRate":0.041317,"preHourTrading":{"tag":"盘前","latestPrice":74.32,"preClose":74.22,"latestTime":"09:16 EDT","volume":283,"amount":20967.179642,"timestamp":1774531018750,"change":0.1,"changeRate":0.001347,"amplitude":0.013473},"postHourTrading":{"tag":"盘后","latestPrice":74.22,"preClose":74.22,"latestTime":"19:03 EDT","volume":89305,"amount":6628217.63,"timestamp":1774479795492,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.285604,"impliedVol":0.2668,"impliedVolPercentile":0.9283},"requestUrl":"/m/hq/s/ADC/wiki","defaultTab":"wiki","newsList":[{"id":"2622867581","title":"$27 XRP Price? Standard Chartered and Analyst Agree: ‘Path Might Shift, But the Targets Always Remain’","url":"https://stock-news.laohu8.com/highlight/detail?id=2622867581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622867581?lang=en_us&edition=fundamental","pubTime":"2026-03-27 00:26","pubTimestamp":1774542388,"startTime":"0","endTime":"0","summary":"XRP (XRP-USD) is currently following a technical path that could lead to a historic price explosion, according to a new analysis. While the token i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/27-xrp-price-standard-chartered-and-analyst-agree-path-might-shift-but-the-targets-always-remain?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/27-xrp-price-standard-chartered-and-analyst-agree-path-might-shift-but-the-targets-always-remain?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4124","BK4080","TOXR","SMP","BK4231","XXRP","ADC","USD","XRPT","XRP","XRPI"],"gpt_icon":0},{"id":"2622686168","title":"Biocytogen Partner NEOK Bio Wins FDA IND Clearance for Bispecific-Based ADC NEOK002","url":"https://stock-news.laohu8.com/highlight/detail?id=2622686168","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622686168?lang=en_us&edition=fundamental","pubTime":"2026-03-26 22:54","pubTimestamp":1774536846,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H ( ($HK:2315) ) has provided an update. Biocytogen Pharmaceuticals (Beijing) Co. Ltd. is a Chi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biocytogen-partner-neok-bio-wins-fda-ind-clearance-for-bispecific-based-adc-neok002?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biocytogen-partner-neok-bio-wins-fda-ind-clearance-for-bispecific-based-adc-neok002?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND","BK4588","LABU","BK4080","BK4231","ADC","BK4585"],"gpt_icon":0},{"id":"1114322224","title":"BIOCYTOGEN-B Partner NEOK Bio Secures FDA IND Clearance for Bispecific ADC NEOK002, Reaching Critical Collaboration Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=1114322224","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114322224?lang=en_us&edition=fundamental","pubTime":"2026-03-26 22:39","pubTimestamp":1774535946,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) announced that its partner, NEOK Bio, Inc., has received Investigational New Drug (IND) approval from the US Food and Drug Administration (FDA) for its investigational drug...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315","IND","BK4588","BK1161","LABU","BK4080","ADC","BK4231","688796","BK4585","BK0216"],"gpt_icon":0},{"id":"2622586668","title":"Sichuan Kelun-Biotech’s SKB103 IND Adds ADC Momentum And Valuation Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2622586668","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622586668?lang=en_us&edition=fundamental","pubTime":"2026-03-26 13:02","pubTimestamp":1774501377,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) has received IND approval in China for SKB103, its first TAA PD-L1 bispecific antibody-drug conjugate.\nSKB103 becomes the company’s second bispecific ADC to reach the clinical stage, following SKB571.\nThe candidate is built on Kelun-Biotech’s proprietary OptiDC™ platform and is designed to combine tumor antigen targeting with PD-L1 immune modulation.\n\nFor investors tracking SEHK:6990, the IND clearance for SKB103 adds another clinical stage...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/sichuan-kelun-biotechs-skb103-ind-adds-adc-momentum-and-valu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/sichuan-kelun-biotechs-skb103-ind-adds-adc-momentum-and-valu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ADC","IND","BK4585","BK4231","LU0196878994.USD","XBI","BK4588","06990","BK4581","BK4080","BK1161"],"gpt_icon":0},{"id":"2622736026","title":"Lepu Biopharma Swings to Profit as ADC Pipeline and Licensing Deals Gain Traction","url":"https://stock-news.laohu8.com/highlight/detail?id=2622736026","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622736026?lang=en_us&edition=fundamental","pubTime":"2026-03-25 16:40","pubTimestamp":1774428056,"startTime":"0","endTime":"0","summary":"Lepu Biopharma Co. Ltd. Class H ( ($HK:2157) ) has shared an announcement. Lepu Biopharma reported a sharp rise in 2025 revenue to about RMB934.9 m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lepu-biopharma-swings-to-profit-as-adc-pipeline-and-licensing-deals-gain-traction?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lepu-biopharma-swings-to-profit-as-adc-pipeline-and-licensing-deals-gain-traction?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4231","ADC","BK4080"],"gpt_icon":0},{"id":"2622937046","title":"Chiba Bank, Chiba Kogyo Bank Agree To Form Holding Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2622937046","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622937046?lang=en_us&edition=fundamental","pubTime":"2026-03-25 11:43","pubTimestamp":1774410183,"startTime":"0","endTime":"0","summary":"The Chiba Kogyo Bank (TYO:8337) and Chiba Bank (TYO:8331) agreed to form a joint holding company, Chiba Financial Group, through a share transfer effective April 1, 2027, according to a Wednesday fili","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4080","BK4231","ADC"],"gpt_icon":0},{"id":"2622147090","title":"Horizon Oil, Mereenie JV Partners Agree to Extend Deadline for Gas Sales Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2622147090","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622147090?lang=en_us&edition=fundamental","pubTime":"2026-03-25 08:18","pubTimestamp":1774397889,"startTime":"0","endTime":"0","summary":"Horizon Oil  and its Mereenie joint venture partners agreed with Northern Territory's Power and Water Corporation to extend the deadline to execute a binding gas sales agreement to April 1 from March 24, according to a Wednesday filing with the Australian bourse.The Mereenie JV partners include Central Petroleum , Echelon Resources , and Cue Energy .Shares of Central Petroleum and Cue Energy fell 3% in morning trade on Wednesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ADC"],"gpt_icon":0},{"id":"2622013941","title":"PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2622013941","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622013941?lang=en_us&edition=fundamental","pubTime":"2026-03-25 04:05","pubTimestamp":1774382700,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., March  24, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the i","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/24/3261723/37149/en/PDS-Biotech-Announces-Conference-Call-and-Webcast-for-2025-Fourth-Quarter-and-Year-End-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","BK4231","PDS","BK4585","XBI","ADC","BK4092","BK4581","BK4588"],"gpt_icon":0},{"id":"2622097796","title":"Martin Shkreli, AOC Agree Kalshi Has A Problem","url":"https://stock-news.laohu8.com/highlight/detail?id=2622097796","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622097796?lang=en_us&edition=fundamental","pubTime":"2026-03-25 02:24","pubTimestamp":1774376640,"startTime":"0","endTime":"0","summary":"Shkreli and AOC agree that Kalshi hasn't gone far enough in policing who can trade on its event markets.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/24/Clint--Texas-----Usa---1-July-2019-Clint.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/24/Clint--Texas-----Usa---1-July-2019-Clint.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/politics/26/03/51441398/martin-shkreli-aoc-agree-kalshi-has-a-problem","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/politics/26/03/51441398/martin-shkreli-aoc-agree-kalshi-has-a-problem","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4231","ADC","BK4080"],"gpt_icon":0},{"id":"2621983370","title":"Dow Jones Slips as Iran ‘Unlikely’ to Agree to U.S. Demands","url":"https://stock-news.laohu8.com/highlight/detail?id=2621983370","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621983370?lang=en_us&edition=fundamental","pubTime":"2026-03-24 21:31","pubTimestamp":1774359066,"startTime":"0","endTime":"0","summary":"The Dow Jones (DJIA) is set to open Tuesday in negative territory as concerns grow over the difficulty of ending the U.S.-Iran war. On Monday, Pres...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/dow-jones-slips-as-iran-unlikely-to-agree-to-u-s-demands?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/dow-jones-slips-as-iran-unlikely-to-agree-to-u-s-demands?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SCHD","DOG","VYM",".DJI","DGRW","DJX","VUG","SDOW","BK4231","UDOW","DDM","ADC","MYMmain","DXD","DIA","SCHG","BK4080","YMmain","DJIA"],"gpt_icon":0},{"id":"2621594062","title":"VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs","url":"https://stock-news.laohu8.com/highlight/detail?id=2621594062","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621594062?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:05","pubTimestamp":1774353900,"startTime":"0","endTime":"0","summary":"ADCs are a major new market; Company demonstrates ability to discern antibody toxicity from payload toxicity and show differential linker chemistry toxicitySAN DIEGO, March  24, 2026 (GLOBE NEWSWIRE) ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/24/3261196/37000/en/VivoSim-Releases-Antibody-Drug-Conjugate-ADC-Data-Showing-Power-to-Detect-ADC-Toxicity-and-Guide-Design-of-Safer-ADCs.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4234","BK4084","BK4080","PW","ADC","BK4231"],"gpt_icon":0},{"id":"2621064585","title":"Press Release: Trian and General Catalyst Agree to Increase Merger Consideration to $52.00 Per Share in Cash for Janus Henderson Group plc and Have Made the Only Actionable Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=2621064585","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621064585?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:00","pubTimestamp":1774353600,"startTime":"0","endTime":"0","summary":"Amended Merger Agreement Represents a $3.00 All-Cash Price Increase; 25% Premium to Unaffected Share Price; Parties Committed to Closing by Mid-2026. Special Committee Determines that Victory Capital's Revised Unsolicited March 17, 2026 Proposal Is Not Actionable and Is Not in Best Interests of Janus Henderson and Its Shareholders. Amended Merger Agreement's All-Cash Transaction With Trian and General Catalyst Is Superior From an Expected Value and Certainty Perspective and Is the Only Actionable Proposal. The Trian/General Catalyst Merger Agreement Provides Superior, Near-Term Value. The enhanced price of $52.00 per share represents a 25% premium to the unaffected closing price of Janus Henderson shares on October 24, 2025, the last trading day before the initial Trian and General Catalyst proposal was made public. Janus Henderson, Trian and General Catalyst have already made significant progress toward closing and have a clear path to satisfying all outstanding conditions. In particu","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4135","IE0031619046.USD","BK4231","IE00B7SZL793.SGD","IE00B3QW5Z07.USD","VCTR","ADC","BK4080","IE00B64PRP62.GBP","LU0054578231.USD","JHG","IE00B66KJ199.SGD","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"2621068695","title":"Kelun-Biotech Receives IND Approval for SKB103, a Novel TAA-PD-L1 Bispecific ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2621068695","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621068695?lang=en_us&edition=fundamental","pubTime":"2026-03-24 17:24","pubTimestamp":1774344240,"startTime":"0","endTime":"0","summary":"CHENGDU, China, March 24, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.  today announced that the Investigational New Drug  application for SKB103, its self-developed novel bispecific antibody-drug conjugate with combined Tumor-Associated Antigen-targeting and Immuno-Oncology mechanisms , has been approved by the Center for Drug Evaluation  of the National Medical Products Administration  of China for the treatment of advanced solid tumors. The approval marks SKB103 as the Company's first TAA-PD-L1 bsADC candidate and its second bsADC program for tumor therapy to enter the clinical stage, following SKB571.Kelun-Biotech  is a holding subsidiary of Kelun Pharmaceutical , which focuses on the R&D, manufacturing, commercialization and global collaboration of innovative biological drugs and small molecule drugs. Kelun-Biotech focuses on major disease areas such as solid tumors, autoimmune, and metabolic diseases, and in establishing a globalized drug development and","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2650617/logo_kelun_Biotech_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2650617/logo_kelun_Biotech_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/kelun-biotech-receives-ind-approval-for-skb103-a-novel-taa-pd-l1-bispecific-adc-302723152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1223083913.SGD","LU2148510915.USD","ADC","BK4023","BK4231","LU1979443071.USD","BK4585","LU1934453819.USD","BK4581","BK4588","CDE.AU","LU1064130708.USD","LU1064131003.USD","LU1169590202.USD","BK0239","LU1223082196.USD","BK4017","CDE","002422","LU1223082519.USD","BK0060","IND","PD","BK4080","XBI","LU1169589451.USD","BK7095","IND.AU","BK7050"],"gpt_icon":0},{"id":"2621050093","title":"Kelun-Biotech Wins NMPA Green Light to Begin Trials of Novel Bispecific ADC SKB103","url":"https://stock-news.laohu8.com/highlight/detail?id=2621050093","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621050093?lang=en_us&edition=fundamental","pubTime":"2026-03-24 17:11","pubTimestamp":1774343516,"startTime":"0","endTime":"0","summary":"An announcement from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H ( ($HK:6990) ) is now available. Sichuan Kelun-Biotech Biopharmaceut...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kelun-biotech-wins-nmpa-green-light-to-begin-trials-of-novel-bispecific-adc-skb103?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kelun-biotech-wins-nmpa-green-light-to-begin-trials-of-novel-bispecific-adc-skb103?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","ADC","BK4231","BK4080","BK4588","BK4585"],"gpt_icon":0},{"id":"2621707065","title":"Agree Realty Is Maintained at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2621707065","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621707065?lang=en_us&edition=fundamental","pubTime":"2026-03-23 23:43","pubTimestamp":1774280580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ADC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 23, 2026 11:43 ET (15:43 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC"],"gpt_icon":0},{"id":"2621270816","title":"Truist Raises Price Target on Agree Realty to $82 From $79, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2621270816","media":"MT Newswires Live","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621270816?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:54","pubTimestamp":1774266872,"startTime":"0","endTime":"0","summary":"Agree Realty (ADC) has an average rating of overweight and mean price target of $84.32, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ADC"],"gpt_icon":0},{"id":"2621708380","title":"Agree Realty price target raised to $82 from $79 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2621708380","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621708380?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:38","pubTimestamp":1774265881,"startTime":"0","endTime":"0","summary":"Truist raised the firm’s price target on Agree Realty (ADC) to $82 from $79 and keeps a Buy rating on the shares as part of a broader research note...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agree-realty-price-target-raised-to-82-from-79-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agree-realty-price-target-raised-to-82-from-79-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC"],"gpt_icon":0},{"id":"2621708386","title":"Agree Realty (ADC) Gets a Buy from Truist Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2621708386","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621708386?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:35","pubTimestamp":1774265721,"startTime":"0","endTime":"0","summary":"In a report released today, Michael Lewis from Truist Financial assigned a Buy rating to Agree Realty, with a price target of $82.00. According to ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/agree-realty-adc-gets-a-buy-from-truist-financial-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/agree-realty-adc-gets-a-buy-from-truist-financial-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","BK4080","BK4231"],"gpt_icon":0},{"id":"2621777207","title":"ADC Therapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2621777207","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621777207?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:02","pubTimestamp":1774263720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ADCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 23, 2026 07:02 ET (11:02 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ADC"],"gpt_icon":0},{"id":"2621777950","title":"Agree Realty Corp : Truist Securities Raises Target Price to $82 From $79","url":"https://stock-news.laohu8.com/highlight/detail?id=2621777950","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621777950?lang=en_us&edition=fundamental","pubTime":"2026-03-23 18:59","pubTimestamp":1774263558,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B0GA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4080","BK4231","ADC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.agreerealty.com","stockEarnings":[{"period":"1week","weight":-0.0613},{"period":"1month","weight":-0.0643},{"period":"3month","weight":0.0251},{"period":"6month","weight":0.0415},{"period":"1year","weight":-0.0121},{"period":"ytd","weight":0.0304}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.0375},{"period":"3month","weight":-0.0486},{"period":"6month","weight":-0.0076},{"period":"1year","weight":0.1414},{"period":"ytd","weight":-0.0368}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Agree Realty Corporation (the Company), a Maryland corporation, is a fully integrated real estate investment trust (REIT) primarily focused on the ownership, acquisition, development and management of retail properties net leased to industry leading tenants. The Company was founded in 1971 by its current Executive Chairman, Richard Agree, and its common stock was listed on the New York Stock Exchange in 1994. As of March 31, 2024, the Company owned 2,161 properties, with a total gross leasable area (GLA) of approximately 44.9 million square feet.","yearOnYearQuotes":[{"month":1,"riseRate":0.59375,"avgChangeRate":-0.003579},{"month":2,"riseRate":0.46875,"avgChangeRate":0.002186},{"month":3,"riseRate":0.5625,"avgChangeRate":0.012381},{"month":4,"riseRate":0.580645,"avgChangeRate":0.002795},{"month":5,"riseRate":0.5,"avgChangeRate":0.015633},{"month":6,"riseRate":0.65625,"avgChangeRate":0.010123},{"month":7,"riseRate":0.65625,"avgChangeRate":0.022845},{"month":8,"riseRate":0.46875,"avgChangeRate":0.002201},{"month":9,"riseRate":0.46875,"avgChangeRate":-0.006321},{"month":10,"riseRate":0.5625,"avgChangeRate":-0.000339},{"month":11,"riseRate":0.65625,"avgChangeRate":0.003584},{"month":12,"riseRate":0.46875,"avgChangeRate":0.00994}],"exchange":"NYSE","name":"Agree","nameEN":"Agree"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Agree(ADC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Agree,ADC,Agree股票,Agree股票老虎,Agree股票老虎国际,Agree行情,Agree股票行情,Agree股价,Agree股市,Agree股票价格,Agree股票交易,Agree股票购买,Agree股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Agree(ADC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction